41 results
Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Thumbnail

D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Thumbnail

D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Thumbnail

- D3.134 - Evaluation of the level of asthma control in the pulmonology-phtisiology department of the Ignace Deen University Hospital

Thumbnail

D3.133 - Association between Asthma and Risk of Respiratory Syncytial Virus-Acute Respiratory Infection in Adults 50 Years or Older Before and After the Covid 19-Pandemic in a Midwest Region of the U.S

Thumbnail

D3.135 - Nasal and respiratory symptoms, functional features, and sensitization to platinum salts in platinum catalysts manufacturing workers

Thumbnail

D3.136 - Worse asthma control in patients with asthma and respiratory allergies in the CAPTURE study: Rationale for developing the RespiratoryAllergyOptimiser

Thumbnail

D3.137 - Effectiveness of Dupilumab in improving Quality of Life in patients with "steroid-resistant" asthma and severe atopic dermatitis

Thumbnail

D3.138 - Asthma remission in EGPA patients: applicability and concordance of the main international guidelines

Thumbnail

D3.139 - Asthma Comorbidities - do they add more cost, A 3-year follow-up study in Réunion Island

Thumbnail

D3.140 - Xiaoqinglong Decoction Combined with Yupingfeng Powder Alleviates Allergic Rhinitis Complicated with Asthma by Inhibiting B Lymphocyte Activation via JAK2/STAT1/MHC-II signaling pathway

Thumbnail

D3.142 - Differential Impact of Heat-not-Burn Tobacco Products and Conventional Cigarettes on Pulmonary Cells and Immune Response

Thumbnail

D3.143 - Seasonal Patterns of Airborne Pollen in Ecuador: Influence of Wet and Dry Seasons on Allergenic Taxa Concentrations